Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study

Find Full text
Publication year
2019
Author(s)
Smits, L.J.T.
Esch, A.A.J. van
Derikx, L.A.A.P.
Boshuizen, R.S.
Jong, D.J. de
Drenth, J.P.H.
Hoentjen, F.
Source
Inflammatory Bowel Diseases, 25, 1, (2019), pp. 172-179
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/202575   https://hdl.handle.net/2066/202575
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.